coronaric chronic disease MedDRA version: 6.1 Level: PT Classification code 10011078
Conditions
Interventions
Trade Name: TORVAST*10CPR 10MG
Pharmaceutical Form: Film-coated tablet
INN or Proposed INN: Atorvastatin
Current Sponsor code: Atorvastatina-CD34
Concentration unit: mg milligram(s)
Concentration typ
Sponsors
OSPEDALE POLICLINICO S. MATTEO
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: age 18-75 years; stable angina pectoris or silent ischemia, documented coronaropaty Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: current or recent statine therapy, ASA or ticlopidine/clopidogrel allergy, IMA (< 3 months), severe trauma, epatic, renal, ematologic disease, neoplasm, pregnancy,...
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: to evaluate the mobilizing endothelial effect of atorvastatin 10 mg and 80 mg induced by four treatment weeks in patients with PCI;Secondary Objective: to define functional characters (clonogenic and angiogenetic)of atorvastatin mobilized endothelial cells; to verify the duration of this mobilizating effect; ...;Primary end point(s): mobilizing endothelial effect of atorvastatin 10 mg and 80 mg induced by four treatment weeks in patients with PCI | — |
Countries
Italy
Outcome results
None listed